Literature DB >> 13674494

[Thrombosis hazard in chlorpromazine and reserpine therapy of endogenous psychoses].

H GRAHMANN, R SUCHENWIRTH.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; PSYCHOSES/therapy; RESERPINE/therapeutic use; THROMBOSIS/etiology and pathogenesis

Mesh：

Substances：

Year:  1959        PMID： 13674494

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  6 in total

Review 1.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.

Authors:  Corrado Barbui; Valentino Conti; Andrea Cipriani
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 3.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

Review 4.  Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.

Authors:  Anna K Jönsson; Johan Schill; Hans Olsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

5.  Rare and Underestimated Association of Pulmonary Embolism and Olanzapine Therapy; Report of Two Cases.

Authors:  Hammam Rasras; Mustapha Beghi; Maryem Samti; Nabila Ismaili; Noha El Ouafi
Journal:  Arch Acad Emerg Med       Date:  2021-02-05

6.  Venous thromboembolism following initiation of atypical antipsychotics in two geriatric patients.

Authors:  Thomas J Maestri; Jessica Koenig; Christine Masuda; Tawny L Smith; Erica C Garcia-Pittman
Journal:  Ment Health Clin       Date:  2018-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.